Tiny tumor clusters may predict colon cancer outcomes
NCT ID NCT06884839
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looked at 30 colorectal cancer patients to see if tumor deposits (small clusters of cancer cells found near the main tumor) can help predict survival and whether the cancer spreads to other organs. Researchers tracked overall survival and the appearance of new metastases in the liver, lungs, bones, or brain. The goal was to better understand how these deposits affect prognosis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
30 people
The number who actually took part.
- Started
-
Apr 2022
- Finished
-
Apr 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This prospective and retrospective study will be conducted on 30 patients with colorectal cancer.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age above 18 years old. * Both sexes. * All Colorectal cancer patients From Stage I to III Colorectal cancer with pathologically positive Tumor deposits. Exclusion Criteria: * Patient took neoadjuvant therapy. * No information available on tumor deposits. * Colorectal cancer is not the only primary cancer. * Patients with incomplete information about follow-up.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colorectal cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Minia University
Minya, Minya Governorate, 61611, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ivosidenib plus mFOLFOXIRI and celecoxib as a treatment for BRAF-targeted therapy-refractory BRAF V600E-mutant colorectal cancer patients: a phase II study
- Can a new drug shrink advanced solid tumors?
- A sharper eye for cancer: new PET tracer targets hidden tumors
- Can a new tracer reveal hidden tumors and metastases?
- Can a new drug shrink tumors that resist standard care?
- Can a new imaging tracer light up hidden tumors?